A jury has awarded $30 million -- the largest med-mal verdict awarded by a Philadelphia panel in recent years -- to the family of a 5-year-old boy whose severe cognitive and developmental deficiencies were alleged to have resulted from the misadministration of a blood-clot-busting medication. However, the actual disposition amount in the case is officially under wraps, as the parties reached a confidential high-low agreement shortly after the jury began deliberations.
Jury Awards $30M in Med-Mal Suit, but High-Low Hides Outcome
The Legal Intelligencer
June 13, 2006